These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2843574)

  • 1. Role of central alpha-1 adrenoceptors in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    J Clin Invest; 1988 Sep; 82(3):885-94. PubMed ID: 2843574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    Brain Res; 1988 Mar; 444(1):184-8. PubMed ID: 2834022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.
    Mignot E; Guilleminault C; Bowersox S; Frusthofer B; Nishino S; Maddaluno J; Ciaranello R; Dement WC
    Brain Res; 1989 Jun; 490(1):186-91. PubMed ID: 2569353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
    Nishino S; Fruhstorfer B; Arrigoni J; Guilleminault C; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1079-84. PubMed ID: 8095546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of central alpha 1- and alpha 2-adrenoceptors in the regulation of vasopressin release and the cardiovascular system.
    Kimura T; Shoji M; Iitake K; Ota K; Matsui K; Yoshinaga K
    Endocrinology; 1984 Apr; 114(4):1426-32. PubMed ID: 6323145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors.
    Reid MS; Tafti M; Nishino S; Siegel JM; Dement WC; Mignot E
    Sleep; 1994 Aug; 17(5):424-35. PubMed ID: 7991953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.
    Reid MS; Tafti M; Geary JN; Nishino S; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):511-22. PubMed ID: 8008205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy.
    Nishino S; Mignot E; Fruhstorfer B; Dement WC; Hayaishi O
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2483-7. PubMed ID: 2928344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undifferentiated effects of calcium antagonists on pressor responses to selective alpha-1 and alpha-2 adrenoceptor agonists in anesthetized, spinal dogs.
    Morita T; Maniwa T; Satoh K; Taira N
    J Pharmacol Exp Ther; 1985 Sep; 234(3):728-34. PubMed ID: 2863372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.
    Nishino S; Tafti M; Reid MS; Shelton J; Siegel JM; Dement WC; Mignot E
    J Neurosci; 1995 Jul; 15(7 Pt 1):4806-14. PubMed ID: 7623112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cataplexy in genetically narcoleptic Dobermans.
    Riehl J; Nishino S; Cederberg R; Dement WC; Mignot E
    Exp Neurol; 1998 Aug; 152(2):292-302. PubMed ID: 9710528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.
    Renaud A; Nishino S; Dement WC; Guilleminault C; Mignot E
    Eur J Pharmacol; 1991 Nov; 205(1):11-6. PubMed ID: 1687464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep fragmentation in canine narcolepsy.
    Kaitin KI; Kilduff TS; Dement WC
    Sleep; 1986; 9(1 Pt 2):116-9. PubMed ID: 3704433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
    Mignot E; Nishino S; Sharp LH; Arrigoni J; Siegel JM; Reid MS; Edgar DM; Ciaranello RD; Dement WC
    J Neurosci; 1993 Mar; 13(3):1057-64. PubMed ID: 8095066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of onset location, laterality and propagation of cataplexy in canine narcolepsy.
    Fujiki N; Morris L; Mignot E; Nishino S
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):275-6. PubMed ID: 12047593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataplexy-related neurons in the amygdala of the narcoleptic dog.
    Gulyani S; Wu MF; Nienhuis R; John J; Siegel JM
    Neuroscience; 2002; 112(2):355-65. PubMed ID: 12044453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleus.
    Fruhstorfer B; Mignot E; Bowersox S; Nishino S; Dement WC; Guilleminault C
    Brain Res; 1989 Oct; 500(1-2):209-14. PubMed ID: 2557958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in narcolepsy research and therapy.
    Mignot E
    Curr Opin Pulm Med; 1996 Nov; 2(6):482-7. PubMed ID: 9363189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.